Forte Capital LLC ADV reduced its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) by 4.1% during the third quarter, Holdings Channel reports. The firm owned 9,418 shares of the company’s stock after selling 400 shares during the period. Forte Capital LLC ADV’s holdings in Thermo Fisher Scientific were worth $1,498,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in TMO. Watch Point Trust Co raised its stake in Thermo Fisher Scientific by 4.3% in the second quarter. Watch Point Trust Co now owns 5,763 shares of the company’s stock valued at $852,000 after buying an additional 240 shares during the last quarter. DNB Asset Management AS raised its stake in Thermo Fisher Scientific by 1.5% in the second quarter. DNB Asset Management AS now owns 72,093 shares of the company’s stock valued at $10,652,000 after buying an additional 1,100 shares during the last quarter. British Columbia Investment Management Corp raised its stake in Thermo Fisher Scientific by 3.3% in the second quarter. British Columbia Investment Management Corp now owns 263,934 shares of the company’s stock valued at $38,999,000 after buying an additional 8,525 shares during the last quarter. CHURCHILL MANAGEMENT Corp raised its stake in Thermo Fisher Scientific by 228.7% in the second quarter. CHURCHILL MANAGEMENT Corp now owns 30,496 shares of the company’s stock valued at $4,506,000 after buying an additional 21,218 shares during the last quarter. Finally, Washington Trust Bank raised its stake in Thermo Fisher Scientific by 68.8% in the second quarter. Washington Trust Bank now owns 2,211 shares of the company’s stock valued at $327,000 after buying an additional 901 shares during the last quarter. Institutional investors own 86.28% of the company’s stock.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) traded down 0.82% during trading on Wednesday, hitting $140.11. 2,166,587 shares of the company’s stock were exchanged. The stock has a market cap of $55.35 billion, a P/E ratio of 28.01 and a beta of 1.24. The firm has a 50-day moving average price of $148.36 and a 200-day moving average price of $151.79. Thermo Fisher Scientific Inc. has a one year low of $119.75 and a one year high of $160.68.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Thursday, October 27th. The company reported $2.03 EPS for the quarter, topping analysts’ consensus estimates of $1.97 by $0.06. Thermo Fisher Scientific had a net margin of 11.10% and a return on equity of 14.95%. The firm earned $4.49 billion during the quarter, compared to analysts’ expectations of $4.39 billion. During the same period in the previous year, the company earned $1.80 EPS. The firm’s revenue for the quarter was up 8.9% compared to the same quarter last year. Equities research analysts expect that Thermo Fisher Scientific Inc. will post $8.25 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, January 16th. Investors of record on Thursday, December 15th will be paid a dividend of $0.15 per share. The ex-dividend date is Tuesday, December 13th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.43%. Thermo Fisher Scientific’s dividend payout ratio is presently 12.00%.

TRADEMARK VIOLATION WARNING: This article was originally published by Daily Political and is the propert of of Daily Political. If you are viewing this article on another publication, it was stolen and reposted in violation of U.S. and international copyright laws. The correct version of this article can be viewed at http://www.dailypolitical.com/2016/11/30/forte-capital-llc-adv-decreases-stake-in-thermo-fisher-scientific-inc-tmo.html.

Several analysts have issued reports on TMO shares. Leerink Swann restated a “buy” rating and set a $175.00 price target on shares of Thermo Fisher Scientific in a research report on Sunday, November 20th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $172.00 price target for the company in a research report on Thursday, October 13th. Bank of America Corp. set a $180.00 price target on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research report on Friday, October 7th. Jefferies Group restated a “hold” rating on shares of Thermo Fisher Scientific in a research report on Thursday, August 4th. Finally, Cleveland Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a report on Friday, September 9th. Two equities research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. Thermo Fisher Scientific has an average rating of “Buy” and a consensus price target of $164.37.

In related news, CEO Marc N. Casper sold 28,797 shares of Thermo Fisher Scientific stock in a transaction dated Friday, September 2nd. The shares were sold at an average price of $151.01, for a total transaction of $4,348,634.97. Following the completion of the transaction, the chief executive officer now directly owns 307,444 shares of the company’s stock, valued at approximately $46,427,118.44. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Marc N. Casper sold 30,000 shares of Thermo Fisher Scientific stock in a transaction dated Thursday, September 1st. The stock was sold at an average price of $151.17, for a total transaction of $4,535,100.00. Following the transaction, the chief executive officer now directly owns 308,647 shares of the company’s stock, valued at $46,658,166.99. The disclosure for this sale can be found here. Corporate insiders own 0.52% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.